Veerhealth Care Peer Comparison

Veerhealth Care Ltd. exhibits weak financial performance compared to its peers, with no revenue or earnings growth, and a high PE ratio suggesting overvaluation. In contrast, Sun Pharmaceutical Industries and Cipla Ltd. are strong overall performers with solid profitability, growth, and attractive valuation metrics, making them the sector leaders.

• • Veerhealth Care Ltd. shows no growth in revenue or earnings, and has the highest PE ratio of 99.69.
• • Sun Pharmaceutical and Cipla Ltd. demonstrate strong revenue growth and profitability, making them top performers.
• • Divi's Laboratories and Torrent Pharmaceuticals are financially stable but face challenges in growth and valuation.
• • Financially risky companies include those with high debt ratios and low margins.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth YoY (8.42%) and strong profitability indicators with ROE at 16.13%.
• • Cipla Ltd.: Solid revenue growth (13.28% YoY), excellent ROE (16.63%), and low PE ratio (23.73) making it attractive.